FMC AG - Refines China Commercial Strategy, Expects One-Time Costs Of €110 Million in Q3
Sept 25 (Reuters) - FRESENIUS MEDICAL CARE AG FMEG.DE:
FMC AG - FRESENIUS MEDICAL CARE REFINES CHINA COMMERCIAL STRATEGY WITH A FOCUS ON LONG-TERM GROWTH AND MARKET LEADERSHIP
FMC AG - PORTFOLIO DECISIONS EXPECTED TO RESULT IN RELATED ONE-TIME COSTS IN Q3 2026 TREATED AS A SPECIAL ITEM
FMC AG - PORTFOLIO OPTIMIZATION ACTIONS ARE EXPECTED TO RESULT IN ONE-TIME COSTS OF €110 MILLION
Further company coverage: FMEG.DE